Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL970031 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL10057437 | 0.97 | ALDH1A1 (0.57) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL10057436 | 0.97 | ALDH1A1 (0.57) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL8934477 | 0.97 | ALDH1A1 (0.63) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL10938078 | 0.94 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL1769967 | 0.94 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL4396037 | 0.94 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL20067026 | 0.94 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL4864 | 0.94 | — | — | |
| SCHEMBL4390929 | 0.92 | ALDH1A1 (0.57) | ALDH1A1TSHRMEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3720835-B1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | BASF SE (DE) | 2022-07-13 | — | — | EP | claimed |
| US-11078146-B2 | Method for preparing ethers of cycloaliphatic or araliphatic diols | BASF SE (DE) | 2021-08-03 | — | — | US | claimed |
| US-20210171427-A1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | BASF SE (DE) | 2021-06-10 | — | — | US | claimed |
| CN-111479795-A | Process for preparing ethers of cycloaliphatic or araliphatic diols | 巴斯夫欧洲公司 | 2020-07-31 | — | — | CN | claimed |
| EP-3720835-B1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | BASF SE (DE) | 2022-07-13 | — | — | EP | disclosed |
| US-11078146-B2 | Method for preparing ethers of cycloaliphatic or araliphatic diols | BASF SE (DE) | 2021-08-03 | — | — | US | disclosed |
| US-20210171427-A1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | BASF SE (DE) | 2021-06-10 | — | — | US | disclosed |
| EP-3720835-A1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | BASF SE (DE) | 2020-10-14 | — | — | EP | disclosed |
| CN-111479795-A | Process for preparing ethers of cycloaliphatic or araliphatic diols | 巴斯夫欧洲公司 | 2020-07-31 | — | — | CN | disclosed |
| WO-2019110464-A1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | BASF SE (DE) | 2019-06-13 | — | — | WO | disclosed |
| US-20120107701-A1 | ELECTROLYTE SOLUTION FOR CHARGEABLE DEVICE, ELECTROLYTE SOLUTION FOR LITHIUM ION SECONDARY BATTERY, AND SECONDARY BATTERY | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20070255064-A1 | Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-01 | — | — | US | disclosed |
| EP-1786780-A1 | IMIDAZOLIUM-METHYL SULFITES FOR USE AS STARTING COMPOUNDS FOR PRODUCING IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-23 | — | — | EP | disclosed |
| WO-2006021303-A1 | IMIDAZOLIUM-METHYL SULFITES FOR USE AS STARTING COMPOUNDS FOR PRODUCING IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171427-A1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | DGKI, MGLL, DEGS1 | ALDH1A1 1489/4885TSHR 2908/4885MEN1 876/4885 |
| US-11078146-B2 | Method for preparing ethers of cycloaliphatic or araliphatic diols | DGKI, MGLL, DEGS1 | ALDH1A1 1489/4885TSHR 2908/4885MEN1 876/4885 |
| US-20070255064-A1 | Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids | CBR3, SCO2, PRMT5 | ALDH1A1 3791/4885TSHR 2749/4885MEN1 2137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.